Aurobindo Pharma unit clears USFDA audit
Aurobindo Pharma announced that the manufacturing unit of Auro Peptides, the synthetic peptides API business arm of the company,
situated at Indrakaran Village, Kandi Mandal, Sangareddy District, Telangana, was audited by the US FDA from 12 - 16 February 2024. The inspection was concluded with zero observations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 16 2024 | 1:10 PM IST